Several lines of evidence declared overexpression of PKM2 in many types of cancers, such as pancreatic ductal adenocarcinoma [66], ovarian cancer [67], and gastric cancer [68], that favor the glycolytic pathway to achieve nutrients demand much faster than oxidative phosphorylation. The gene discussed is PKM; the disease is cancer.